Clinical Trial Update: Melanoma Checkpoint and Gut Microbiome Alteration With Microbiome Intervention [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating a gut microbiome intervention in patients with metastatic melanoma to explore effects on checkpoint-related responses. The study result…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Snippet

Sponsor: Parker Institute for Cancer Immunotherapy | Conditions: Metastatic Melanoma | Phase 1 | Status: COMPLETED | Results posted: 2024-06-06